Vebreltinib Clinical Trials
3 recruitingDrug
Phase 23Phase 11
Showing 1–3 of 3 trials
Recruiting
Phase 2
Vebreltinib for Advanced or Metastatic CCS
Clear Cell Sarcoma (CCS)
Second Affiliated Hospital, School of Medicine, Zhejiang University30 enrolled1 locationNCT07153887
Recruiting
Phase 1Phase 2
Vebreltinib Plus PLB1004 in EGFR-mutated, Advanced NSCLC With MET Amplification or MET Overexpression Following EGFR-TKI
Avistone Biotechnology Co., Ltd.156 enrolled1 locationNCT06343064
Recruiting
Phase 2
Vebreltinib Plus PLB1004 as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLC.
Avistone Biotechnology Co., Ltd.120 enrolled1 locationNCT06574347